Team
)
EDUCATION AND TRAINING
BIOGRAPHY
Dr. Carrau is a Uruguayan virologist with main expertise in emerging viruses and virus evolution. During her PhD she worked in in vitro and in vivo experimental evolution approaches on the picornavirus Coxsackievirus B3 and in the alphavirus chikungunya virus. This work led to the development of a novel live attenuated vaccine against chikungunya virus. For her next project she worked in the emerging arboviruses Mayaro and Usutu virus, considered to have high potential to cause outbreaks in the human population. In 2020 she joined the tenOever lab as a postdoctoral fellow, working mainly on animal models to study the host response and therapeutics against SARS-CoV-2.
PUBLICATIONS
Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2
Reiterer M, Rajan M, Gómez-Banoy N, Lau JD, Gomez-Escobar LG, Ma L, Gilani A, Alvarez-Mulett S, Sholle ET, Chandar V, Bram Y, Hoffman K, Bhardwaj P, Piloco P, Rubio-Navarro A, Uhl S, Carrau L, Houhgton S, Redmond D, Shukla AP, Goyal P, Brown KA, tenOever BR, Alonso LC, Schwartz RE, Schenck EJ, Safford MM, Lo JC.
Cell Metablism 07/12/2021
PMID: 34879241
Immune memory from SARS-CoV-2 infection in hamsters provides variant-independent protection but still allows virus transmission
Horiuchi and Oishi et al.
Sci. Immunology 26/10/2021
Cardiomyocytes recruit monocytes upon SARS-CoV-2 infection by secreting CCL2
Yang et al.
Stem Cell Reports 12/10/2021
Phylogenetic and genome wide deep sequencing analyses of canine parvovirus reveal co-infection with field variants and emergence of a recombinant strain.
Perez, R; Calleros, L; Marandino, A; Sarute, N; Iraola, G; Grecco, S; Blanc, H; Vignuzzi, M; Isakov, O; Shomron, N; Carrau, L; Hernández, M; Francia, L; Sosa, K; Tomás, G & Panzera, Y
PLoS ONE 02/12/2020
PMID: 25365348